Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Cardiol Therapeutics Inc (CRDL.TO)

Cardiol Therapeutics Inc (CRDL.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Stocks in play: Cardiol Therapeutics Inc. Baystreet - Tue Jul 14, 8:33AM CDT

Announced the publication of its Phase II MAvERIC study results in the Journal of the American Heart ...

CRDL.TO : 1.67 (-4.02%)
Cardiol Therapeutics' Phase II Recurrent Pericarditis Data Published in the Journal of the American Heart Association PR Newswire - Tue Jul 14, 6:27AM CDT

• Peer-reviewed JAHA publication strengthens the foundation for Cardiol's pivotal Phase III MAVERIC trial as enrollment nears completion.

CRDL.TO : 1.67 (-4.02%)
CRDL : 1.1800 (-4.07%)
Cardiol Therapeutics' Phase II Recurrent Pericarditis Data Published in the Journal of the American Heart Association PR Newswire - Tue Jul 14, 6:27AM CDT

• Peer-reviewed JAHA publication strengthens the foundation for Cardiol's pivotal Phase III MAVERIC trial as enrollment nears completion.

CRDL.TO : 1.67 (-4.02%)
CRDL : 1.1800 (-4.07%)
Cardiol Therapeutics to Participate in Fireside Chat at B. Riley Securities Mind, Muscle & Vision Summit PR Newswire - Thu Jul 9, 6:27AM CDT

TORONTO , July 9, 2026 /PRNewswire/ - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) (" Cardiol " or the " Company "), a late-stage life sciences company advancing anti-inflammatory...

CRDL.TO : 1.67 (-4.02%)
CRDL : 1.1800 (-4.07%)
Stocks in play: Cardiol Therapeutics Inc. Baystreet - Thu Jun 25, 9:00AM CDT

Announces the results from its Annual General Meeting of Shareholders held virtually via live audio ...

CRDL.TO : 1.67 (-4.02%)
Cardiol Therapeutics Reports Results of 2026 Annual General Meeting of Shareholders PR Newswire - Thu Jun 25, 6:27AM CDT

TORONTO , June 25, 2026 /PRNewswire/ - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a late-stage life sciences company advancing anti-inflammatory and anti-fibrotic...

CRDL.TO : 1.67 (-4.02%)
CRDL : 1.1800 (-4.07%)
Cardiol Therapeutics Reports Results of 2026 Annual General Meeting of Shareholders PR Newswire - Thu Jun 25, 6:27AM CDT

TORONTO , June 25, 2026 /CNW/ - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a late-stage life sciences company advancing anti-inflammatory and anti-fibrotic...

CRDL.TO : 1.67 (-4.02%)
CRDL : 1.1800 (-4.07%)
Stocks in play: Cardiol Therapeutics Inc. Baystreet - Tue Jun 23, 9:05AM CDT

Announces that the Company's virtual Annual General Meeting of Shareholders will be webcast on June ...

CRDL.TO : 1.67 (-4.02%)
Cardiol Therapeutics to Webcast Virtual Annual General Meeting of Shareholders on June 24th at 4:30 p.m. EDT PR Newswire - Tue Jun 23, 6:27AM CDT

TORONTO , June 23, 2026 /PRNewswire/ - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a late-stage life sciences company advancing anti-inflammatory and anti-fibrotic...

CRDL.TO : 1.67 (-4.02%)
CRDL : 1.1800 (-4.07%)
Stocks in play: Cardiol Therapeutics Inc. Baystreet - Thu May 14, 10:54AM CDT

Will participate in a Fireside Chat at the H.C. Wainwright 4th Annual BioConnect Investor Conference ...

CRDL.TO : 1.67 (-4.02%)

Barchart Exclusives

No Matter Who Wins the Smartphone and AI Chip Races, ARM Stock Still Benefits Barchart - Sat Jul 25, 2:30PM CDT
Arm now leads x86 in AI servers and collects royalties from every chipmaker, including the ones it competes with. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.